Updater IPO vs Valiant Laboratories IPO

Comparison between Updater IPO and Valiant Laboratories IPO.

IPO Details

Updater IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Valiant Laboratories IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Updater IPO is up to ₹640.00 Cr whereas the issue size of the Valiant Laboratories IPO is up to ₹152.46 Cr. The final issue price of Updater IPO is ₹300.00 per share and of Valiant Laboratories IPO is ₹140.00 per share.

 Updater IPOValiant Laboratories IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹280.00 per share₹133.00 per share
Issue Price (Upper)₹300.00 per share₹140.00 per share
Issue Price (Final)₹300.00 per share₹140.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size50 shares105 shares
Fresh Issue Size1,33,33,333 shares1,08,90,000 shares
Fresh Issue Size (Amount)up to ₹400.00 Crup to ₹152.46 Cr
OFS Issue Size80,00,000 shares0 shares
OFS Issue Size (Amount)up to ₹240.00 Crup to ₹0.00 Cr
Issue Size Total2,13,33,333 shares1,08,90,000 shares
Issue Size Total (Amount)up to ₹640.00 Crup to ₹152.46 Cr

IPO Timetable

Updater IPO opens on Sep 25, 2023, while Valiant Laboratories IPO opens on Sep 27, 2023. The closing date of Updater IPO and Valiant Laboratories IPO is Sep 27, 2023, and Oct 03, 2023, respectively.

 Updater IPOValiant Laboratories IPO
Anchor Bid DateSep 22, 2023Sep 26, 2023
Issue OpenSep 25, 2023Sep 27, 2023
Issue CloseSep 27, 2023Oct 03, 2023
Basis Of Allotment (Tentative)Sep 28, 2023Oct 05, 2023
Initiation of Refunds (Tentative)Sep 29, 2023Oct 06, 2023
Credit of Share (Tentative)Oct 03, 2023Oct 06, 2023
Listing date (Tentative)Oct 04, 2023Oct 06, 2023
Anchor Lockin End date 1Oct 28, 2023Nov 04, 2023
Anchor Lockin End date 2Dec 27, 2023Jan 03, 2024

Financials & KPIs

Updater IPO P/E ratio is 44.31, as compared to Valiant Laboratories IPO P/E ratio of 15.71.

 Updater IPOValiant Laboratories IPO
Financials

Company Financials (Restated Consolidated)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets1,216.95874.57579.49
Total Income2,112.091,497.891,216.35
Profit After Tax34.6157.3747.56
NET Worth380.89340.43285.26
Total Borrowing176.5458.6811.61
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets212.76181.81106.31
Total Income338.77293.47183.78
Profit After Tax29.0027.5030.59
NET Worth100.4971.4688.58
Total Borrowing59.4060.680.35
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)80.58100.00
Promoter Shareholding (Post-Issue)58.4774.94
P/E Ratio44.3115.71
Market Cap₹2001.00 Cr.₹608.30 Cr.
ROE9.40%33.73%
ROCE14.17%22.76%
Debt/Equity0.460.59
EPS₹6.77₹8.91
RoNW9.34%28.86%

Shares Offered

In the Updater IPO Retail Individual Investors (RII) are offered 21,33,333 shares while in Valiant Laboratories IPO retail investors are offered 21,33,333 shares. Qualified Institutional Buyers (QIB) are offered 64,00,001 shares in Updater IPO and 21,78,030 shares in Valiant Laboratories IPO.

 Updater IPOValiant Laboratories IPO
Anchor Investor Reservation96,00,000 shares32,66,970 shares
Market Maker Reservation
QIB64,00,001 shares21,78,030 shares
NII31,99,999 shares16,33,500 shares
RII21,33,333 shares38,11,500 shares
Employee
Others
Total2,13,33,333 shares1,08,90,000 shares

Bids Received (Subscription)

Updater IPO subscribed 2.96x in total, whereas Valiant Laboratories IPO subscribed 29.76x.

 Updater IPOValiant Laboratories IPO
QIB (times)4.50x20.83x
NII (times)0.89x73.64x
Big NII (times)1.07x78.64x
Small NII (times)0.53x63.64x
RII (times)1.45x16.06x
Employee (times)
Other (times)
Total (times)2.96x29.76x

Compare with others

Compare: